Amgen (AMGN) PT Lowered to $333 at Morgan Stanley
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $410.24 --0%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 29
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 29
Join SI Premium – FREE
Morgan Stanley analyst Terance Flynn lowered the price target on Amgen (NASDAQ: AMGN) to $333.00 (from $340.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Canaccord Reiterates Hold Rating on Amgen (AMGN)
- Amgen (AMGN) PT Raised to $410 at Jefferies
- Anixa Biosciences (ANIX) PT Lowered to $6 at H.C. Wainwright
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
